Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Graham Holdings Co is an education & training services business based in the US. Graham shares (GHC) are listed on the NYSE and all prices are listed in US Dollars. Graham employs 12,102 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $561.19 |
|---|---|
| 52-week range | $533.77 - $671.47 |
| 50-day moving average | $596.45 |
| 200-day moving average | $594.93 |
| Wall St. target price | $610.00 |
| PE ratio | 8.1786 |
| Dividend yield | $6.11 (1.16%) |
| Earnings per share (TTM) | $67.41 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $561.19 from 2022-06-29
| 1 week (2022-06-24) | -0.44% |
|---|---|
| 1 month (2022-05-28) | N/A |
| 3 months (2022-03-31) | -8.22% |
| 6 months (2021-12-31) | -10.90% |
| 1 year (2021-07-01) | -12.04% |
|---|---|
| 2 years (2020-07-01) | 66.54% |
| 3 years (2019-07-01) | 702.06 |
| 5 years (2017-06-30) | 599.65 |
Valuing Graham stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Graham's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Graham's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Graham shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Graham's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $379.5 million.
The EBITDA is a measure of a Graham's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.4 billion |
|---|---|
| Operating margin TTM | 7.27% |
| Gross profit TTM | $1.1 billion |
| Return on assets TTM | 2.22% |
| Return on equity TTM | 8.04% |
| Profit margin | 9.89% |
| Book value | $913.64 |
| Market capitalisation | $2.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 16.06% of net profits
Recently Graham has paid out, on average, around 16.06% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Graham shareholders could enjoy a 1.16% return on their shares, in the form of dividend payments. In Graham's case, that would currently equate to about $6.11 per share.
While Graham's payout ratio might seem low, this can signify that Graham is investing more in its future growth.
Graham's most recent dividend payout was on 4 August 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 July 2022 (the "ex-dividend date").
Graham's shares were split on a 1655:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1655 shares. This wouldn't directly have changed the overall worth of your Graham shares – just the quantity. However, indirectly, the new 39.6% lower share price could have impacted the market appetite for Graham shares which in turn could have impacted Graham's share price.
Over the last 12 months, Graham's shares have ranged in value from as little as $533.77 up to $671.4736. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Graham's is 1.0495. This would suggest that Graham's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company worldwide. It provides test preparation services and materials; data science and training services; professional training and exam preparation for professional certifications and licensures; and non-academic operations support services to the Purdue University Global. The company also offers training, test preparation, and degrees for accounting and financial services professionals; English-language training, academic preparation programs, and test preparation for English proficiency exams; and A-level examination preparation services, as well as operates three colleges, a business school, a higher education institution, and an online learning institution. In addition, it owns and operates seven television stations; and provides social media management tools to connect newsrooms with their users, as well as produces Foreign Policy magazine and ForeignPolicy. com website. Further, the company publishes Slate, an online magazine; and two French-language news magazine websites at slate. fr and slateafrique.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.